Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 199-203

  Tan, Changhong ^a   Liu, Yi ^a   Li, Weina ^a   Deng, Fen ^a   Liu, Xi ^a   Wang, Xin ^a   Gui, Yuejiang ^a   Qin, Lu ^a   Hu, Changlin ^a   Chen, Lifen ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Carotid atherosclerosis; Intima media thickness; Plaque score; Serum matrix metalloproteinase 9; Serum monocyte chemoattractant protein 1

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; URIC ACID;

ADULT; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

CAROTID ATHEROSCLEROSIS; INTIMA-MEDIA THICKNESS; PLAQUE SCORE; SERUM MATRIX METALLOPROTEINASE-9; SERUM MONOCYTE CHEMOATTRACTANT PROTEIN-1;

ADULT; AGED; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; URIC ACID;

EID: 84891603907     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.040     Document Type: Article

References (40)

1. Chambless L.E., Folsom A.R., Clegg L.X., et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000, 151:478-487.
2. Iglesias del Sol A., Bots M.L., Grobbee D.E., Hofman A., Witteman J.C. Carotid intima-media thickness at different sites: relation to incident myocardial infarction; the Rotterdam Study. Eur Heart J 2002, 23:934-940.
3. Hollander M., Hak A.E., Koudstaal P.J., et al. Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 2003, 34:2367-2372.
4. Kitamura A., Iso H., Imano H., et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004, 35:2788-2794.
5. Lorenz M.W., von Kegler S., Steinmetz H., Markus H.S., Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006 Jan, 37(1):87-92.
6. Cao J.J., Arnold A.M., Manolio T.A., et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 2007 Jul 3, 116(1):32-38.
7. Mathiesen E.B., Johnsen S.H., Wilsgaard T., Bønaa K.H., Løchen M.L., Njølstad I. Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromsø Study. Stroke 2011 Apr, 42(4):972-978.
8. Sapienza P., di Marzo L., Borrelli V., et al. Metalloproteinases and their inhibitors are markers of plaque instability. Surgery 2005, 137:355-363.
9. Johnson J.L., Jackson C.L., Angelini G.D., et al. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1998, 18:1707-1715.
10. Loftus I.M., Goodall S., Crowther M., et al. Increased MMP9 activity in acute carotid plaques: therapeutic avenues to prevent stroke. Ann N Y Acad Sci 1999, 878:551-554.
11. Ghilardi G., Biondi M.L., DeMonti M., et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002, 33:2408-2412.
12. Alvarez B., Ruiz C., Chacon P., et al. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. JVasc Surg 2004, 40:469-475.
13. Formato M., Farina M., Spirito R., et al. Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries. Arterioscler Thromb Vasc Biol 2004, 24:129-135.
14. Sluijter J.P., Pulskens W.P., Schoneveld A.H., et al. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms. Stroke 2006 Jan, 37(1):235-239.
15. Stintzing S., Heuschmann P., Barbera L., et al. Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis. Ann Vasc Surg 2005 May, 19(3):310-319.
16. Heo S.H., Cho C.H., Kim H.O., et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. JClin Neurol 2011 Jun, 7(2):69-76.
17. Romero J.R., Vasan R.S., Beiser A.S., et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study. JStroke Cerebrovasc Dis 2008, 17:412-417.
18. Olson F.J., Schmidt C., Gummesson A., et al. Circulating matrix metalloproteinase9 levels in relation to sampling methods, femoral and carotid atherosclerosis. JIntern Med 2008, 263:626-635. 13.
19. Lien L.M., Hsieh Y.C., Bai C.H., et al. Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan. Atherosclerosis 2010 Oct, 212(2):595-600.
20. de Lemos J.A., Morrow D.A., Sanatine M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003, 107:690-695.
21. Arakelyan A., Petrkova J., Hermanova Z., Boyajyan A., Lukl J., Petrek M. Serum levels of the MCP-1 chemokine in patients with ischemic stroke and myocardial infarction. Mediators Inflamm 2005, 3:175-179.
22. Uchida E., Anan F., Masaki T., et al. Monocyte chemoattractant protein-1 is associated with silent cerebral infarction in patients on haemodialysis. Intern Med J 2012 Jan, 42(1):29-34.
23. Canouï-Poitrine F., Luc G., Mallat Z., et al. Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study. Neurology 2011 Sep 20, 77(12):1165-1173. PRIME Study Group.
24. Sutton-Tyrrell K., Wolfson S.K., Thompson T., Kelsey S.F. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke 1992 Feb, 23(2):215-220.
25. Crouse J.R., Harpold G.H., Kahl F.R., Toole J.F., McKinney W.M. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound. Stroke 1986, 17:270-275.
26. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4thwatching the risk symposium, 13th and 15th European stroke conferences. Cerebrovasc Dis 2007, 23:75-80.
27. Nambi V., Chambless L., Folsom A.R., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study. JAm Coll Cardiol 2010 Apr 13, 55(15):1600-1607.
28. Dupont W.D., Plummer W.D. Power and sample Size calculations: a review and computer program. Control Clin Trials 1990, 11:116-128.
29. Deo R., Khera A., McGuire D.K., et al. Association among plasma levels of monocyte chemoattractant protein-1,traditional cardiovascular risk factors, and subclinical atherosclerosis. JAm Coll Cardiol 2004 Nov 2, 44(9):1812-1818.
30. Thakore A.H., Guo C.Y., Larson M.G., et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007, 99:1598-1602.
31. Cao J.J., Thach C., Manolio T.A., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003 Jul 15, 108(2):166-170.
32. Alizadeh Dehnavi R., de Roos A., Rabelink T.J., et al. Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesity. Atherosclerosis 2008 Oct, 200(2):417-423.
33. Teupser D., Weber O., Rao T.N., Sass K., Thiery J., Fehling H.J. No reduction of atherosclerosis in C-reactive protein (CRP)-deficient mice. JBiol Chem 2011 Feb 25, 286(8):6272-6279.
34. Koike T., Kitajima S., Yu Y., et al. Human C-reactive protein does not promote atherosclerosis in transgenic rabbits. Circulation 2009, 120:2088-2094.
35. Rozalski R., Migdalski A., Gackowski D., et al. Does morphology of carotid plaque depend on patient's oxidative stressα. Clin Biochem 2013 Aug, 46(12):1030-1035.
36. Dehghan A., Dupuis J., Barbalic M., et al. Meta-analysis of genome-wide association studies in >80,000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011, 123:731-738.
37. Li Q., Yang Z., Lu B., et al. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 2011 Aug 4, 10:72.
38. Takayama S., Kawamoto R., Kusunoki T., Abe M., Onji M. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovasc Diabetol 2012 Jan 10, 11:2.
39. Kanellis J., Watanabe S., Li J.H., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
40. Baldwin W.M.S., Marek G., Wymer D., et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011, 60:1258-1269.